Preparation of human vascular endothelial growth factor-D for structural and preclinical therapeutic studies

Protein Expression and Purification

Volumn 82, Issue 1, 2012, Pages 232-239

  Davydova, Natalia ^a,b   Streltsov, Victor A ^c   Roufail, Sally ^a,b   Lovrecz, George O ^c   Stacker, Steven A ^a,b   Adams, Timothy E ^c   Achen, Marc G ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c CSIRO   (Australia)

Author keywords

Deglycosylation; Human mature VEGF D; Lymphangiogenesis; Protein expression and purification

Indexed keywords

VASCULOTROPIN D;

ARTICLE; CELL LINE; CHEMISTRY; CRYSTALLIZATION; GENE EXPRESSION; GENE VECTOR; GENETICS; GLYCOSYLATION; HUMAN; ISOLATION AND PURIFICATION; MUTATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE;

CELL LINE; CRYSTALLIZATION; GENE EXPRESSION; GENETIC VECTORS; GLYCOSYLATION; HUMANS; MUTATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

ANIMALIA;

EID: 84856568731     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2012.01.001     Document Type: Article

References (52)

1. L.A. Sullivan, and R.A. Brekken The VEGF family in cancer and antibody-based strategies for their inhibition MAbs 2 2010 165 175
2. C. Wiesmann, G. Fuh, H.W. Christinger, C. Eigenbrot, J.A. Wells, and A.M. de Vos Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor Cell 91 1997 695 704 (Pubitemid 27513660)
3. H.W. Christinger, G. Fuh, A.M. de Vos, and C. Wiesmann The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1 J. Biol. Chem. 279 2004 10382 10388 (Pubitemid 38372646)
4. V.M. Leppanen, A.E. Prota, M. Jeltsch, A. Anisimov, N. Kalkkinen, T. Strandin, H. Lankinen, A. Goldman, K. Ballmer-Hofer, and K. Alitalo Structural determinants of growth factor binding and specificity by VEGF receptor 2 Proc. Natl. Acad. Sci. USA 107 2010 2425 2430
5. V.M. Leppanen, M. Jeltsch, A. Anisimov, D. Tvorogov, K. Aho, N. Kalkkinen, P. Toivanen, S. Yla-Herttuala, K. Ballmer-Hofer, and K. Alitalo Structural determinants of vascular endothelial growth factor-D receptor binding and specificity Blood 117 2011 1507 1515
6. T.V. Byzova, C.K. Goldman, J. Jankau, J. Chen, G. Cabrera, M.G. Achen, S.A. Stacker, K.A. Carnevale, M. Siemionow, S.R. Deitcher, and P.E. DiCorleto Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo Blood 99 2002 4434 4442 (Pubitemid 34627212)
7. T.T. Rissanen, J.E. Markkanen, M. Gruchala, T. Heikura, A. Puranen, M.I. Kettunen, I. Kholova, R.A. Kauppinen, M.G. Achen, S.A. Stacker, K. Alitalo, and S. Yla-Herttuala VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses Circ. Res. 92 2003 1098 1106 (Pubitemid 36665855)
8. L.M. Wise, N. Ueda, N.H. Dryden, S.B. Fleming, C. Caesar, S. Roufail, M.G. Achen, S.A. Stacker, and A.A. Mercer Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens J. Biol. Chem. 278 2003 38004 38014 (Pubitemid 37175331)
9. S. Bhardwaj, H. Roy, M. Gruchala, H. Viita, I. Kholova, I. Kokina, M.G. Achen, S.A. Stacker, M. Hedman, K. Alitalo, and S. Yla-Herttuala Angiogenic responses of vascular endothelial growth factors in periadventitial tissue Hum. Gene. Ther. 14 2003 1451 1462 (Pubitemid 37268223)
10. J. Rutanen, T.T. Rissanen, J.E. Markkanen, M. Gruchala, P. Silvennoinen, A. Kivela, A. Hedman, M. Hedman, T. Heikura, M.R. Orden, S.A. Stacker, M.G. Achen, J. Hartikainen, and S. Yla-Herttuala Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart Circulation 109 2004 1029 1035 (Pubitemid 38282857)
11. P. Haiko, T. Makinen, S. Keskitalo, J. Taipale, M.J. Karkkainen, M.E. Baldwin, S.A. Stacker, M.G. Achen, and K. Alitalo Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos Mol. Cell Biol. 28 2008 4843 4850
12. J. Rutanen, P. Leppanen, T.T. Tuomisto, T.T. Rissanen, M.O. Hiltunen, I. Vajanto, M. Niemi, T. Hakkinen, K. Karkola, S.A. Stacker, M.G. Achen, K. Alitalo, and S. Yla-Herttuala Vascular endothelial growth factor-D expression in human atherosclerotic lesions Cardiovasc. Res. 59 2003 971 979 (Pubitemid 38366253)
13. S.A. Stacker, C. Caesar, M.E. Baldwin, G.E. Thornton, R.A. Williams, R. Prevo, D.G. Jackson, S. Nishikawa, H. Kubo, and M.G. Achen VEGF-D promotes the metastatic spread of tumor cells via the lymphatics Nat. Med. 7 2001 186 191 (Pubitemid 32148485)
14. Z. Von Marschall, A. Scholz, S.A. Stacker, M.G. Achen, D.G. Jackson, F. Alves, M. Schirner, M. Haberey, K.H. Thierauch, B. Wiedenmann, and S. Rosewicz Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer Int. J. Oncol. 27 2005 669 679
15. L. Kopfstein, T. Veikkola, V.G. Djonov, V. Baeriswyl, T. Schomber, K. Strittmatter, S.A. Stacker, M.G. Achen, K. Alitalo, and G. Christofori Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis Am. J. Pathol. 170 2007 1348 1361 (Pubitemid 47339341)
16. M.G. Achen, and S.A. Stacker Molecular control of lymphatic metastasis Ann. NY Acad. Sci. 1131 2008 225 234 (Pubitemid 351758517)
17. W. Debinski, B. Slagle-Webb, M.G. Achen, S.A. Stacker, E. Tulchinsky, G.Y. Gillespie, and D.M. Gibo VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme Mol. Med. 7 2001 598 608 (Pubitemid 34175288)
18. M.G. Achen, and S.A. Stacker Tumor lymphangiogenesis and metastatic spread-new players begin to emerge Int. J. Cancer 119 2006 1755 1760 (Pubitemid 44356830)
19. S.A. Stacker, R.A. Williams, and M.G. Achen Lymphangiogenic growth factors as markers of tumor metastasis APMIS 112 2004 539 549 (Pubitemid 39626059)
20. M.G. Achen, M. Jeltsch, E. Kukk, T. Makinen, A. Vitali, A.F. Wilks, K. Alitalo, and S.A. Stacker Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) Proc. Natl. Acad. Sci. USA 95 1998 548 553 (Pubitemid 28083780)
21. M.E. Baldwin, S. Roufail, M.M. Halford, K. Alitalo, S.A. Stacker, and M.G. Achen Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis J. Biol. Chem. 276 2001 44307 44314
22. B.K. McColl, K. Paavonen, T. Karnezis, N.C. Harris, N. Davydova, J. Rothacker, E.C. Nice, K.W. Harder, S. Roufail, M.L. Hibbs, P.A. Rogers, K. Alitalo, S.A. Stacker, and M.G. Achen Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2 FASEB J. 21 2007 1088 1098 (Pubitemid 46495698)
23. S.A. Stacker, K. Stenvers, C. Caesar, A. Vitali, T. Domagala, E. Nice, S. Roufail, R.J. Simpson, R. Moritz, T. Karpanen, K. Alitalo, and M.G. Achen Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers J. Biol. Chem. 274 1999 32127 32136
24. N.C. Harris, K. Paavonen, N. Davydova, S. Roufail, T. Sato, Y.F. Zhang, T. Karnezis, S.A. Stacker, and M.G. Achen Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer FASEB J. 25 2011 2615 2625
25. N.Q. McDonald, and W.A. Hendrickson A structural superfamily of growth factors containing a cystine knot motif Cell 73 1993 421 424 (Pubitemid 23143340)
26. V.M. Leppanen, M. Jeltsch, A. Anisimov, D. Tvorogov, K. Aho, N. Kalkkinen, P. Toivanen, S. Yla-Herttuala, K. Ballmer-Hofer, and K. Alitalo Structural determinants of vascular endothelial growth factor-D - receptor binding and specificity Blood 117 2011 1507 1515
27. P.I. Toivanen, T. Nieminen, L. Viitanen, A. Alitalo, M. Roschier, S. Jauhiainen, J.E. Markkanen, O.H. Laitinen, T.T. Airenne, T.A. Salminen, M.S. Johnson, K.J. Airenne, and S. Yla-Herttuala Novel vascular endothelial growth factor D variants with increased biological activity J. Biol. Chem. 284 2009 16037 16048
28. A. Anisimov, A. Alitalo, P. Korpisalo, J. Soronen, S. Kaijalainen, V.M. Leppanen, M. Jeltsch, S. Yla-Herttuala, and K. Alitalo Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle Circ. Res. 104 2009 1302 1312
29. S.J. Davis, M.J. Puklavec, D.A. Ashford, K. Harlos, E.Y. Jones, D.I. Stuart, and A.F. Williams Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2 Protein Eng. 6 1993 229 232 (Pubitemid 23100805)
30. M.J. Evans, S.L. Hartman, D.W. Wolff, S.A. Rollins, and S.P. Squinto Rapid expression of an anti-human C5 chimeric Fab utilizing a vector that replicates in COS and 293 cells J. Immunol. Methods 184 1995 123 138
31. L. Ge, and P. Rudolph Simultaneous introduction of multiple mutations using overlap extension PCR Biotechniques 22 1997 28 30 (Pubitemid 27036405)
32. P. Stanley Selection of specific wheat germ agglutinin-resistant (WgaR) phenotypes from Chinese hamster ovary cell populations containing numerous lecR genotypes Mol. Cell Biol. 1 1981 687 696 (Pubitemid 11055766)
33. M.G. Achen, S. Roufail, T. Domagala, B. Catimel, E.C. Nice, D.M. Geleick, R. Murphy, A.M. Scott, C. Caesar, T. Makinen, K. Alitalo, and S.A. Stacker Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3 Eur. J. Biochem. 267 2000 2505 2515 (Pubitemid 30304244)
34. N. Sreerama, and R.W. Woody Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set Anal. Biochem. 287 2000 252 260 (Pubitemid 32006234)
35. T.H. Plummer Jr., J.H. Elder, S. Alexander, A.W. Phelan, and A.L. Tarentino Demonstration of peptide:N-glycosidase F activity in endo-beta-N-acetylglucosaminidase F preparations J. Biol. Chem. 259 1984 10700 10704 (Pubitemid 14031193)
36. A.L. Tarentino, and F. Maley Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus J. Biol. Chem. 249 1974 811 817
37. A.J. Petrescu, A.L. Milac, S.M. Petrescu, R.A. Dwek, and M.R. Wormald Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding Glycobiology 14 2004 103 114 (Pubitemid 38263095)
38. N. Sreerama, and R.W. Woody Structural composition of betaI- and betaII-proteins Protein Sci. 12 2003 384 388
39. B. Brandner, R. Kurkela, P. Vihko, and A.J. Kungl Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding Biochem. Biophys. Res. Commun. 340 2006 836 839 (Pubitemid 43053905)
40. N. Davydova, S. Roufail, V.A. Streltsov, S.A. Stacker, and M.G. Achen The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor binding J. Mol. Biol. 407 2011 581 593
41. R. Shayan, M.G. Achen, and S.A. Stacker Lymphatic vessels in cancer metastasis: bridging the gaps Carcinogenesis 27 2006 1729 1738 (Pubitemid 44307827)
42. M.E. Baldwin, S.A. Stacker, and M.G. Achen Molecular control of lymphangiogenesis Bioessays 24 2002 1030 1040 (Pubitemid 35326161)
43. S. Iyer, D.D. Leonidas, G.J. Swaminathan, D. Maglione, M. Battisti, M. Tucci, M.G. Persico, and K.R. Acharya The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution J. Biol. Chem. 276 2001 12153 12161
44. S. Iyer, P.D. Scotney, A.D. Nash, and K. Ravi Acharya Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding J. Mol. Biol. 359 2006 76 85
45. M. Orlandini, A. Spreafico, M. Bardelli, M. Rocchigiani, A. Salameh, S. Nucciotti, C. Capperucci, B. Frediani, and S. Oliviero Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation J. Biol. Chem. 281 2006 17961 17967 (Pubitemid 44035595)
46. S.D. Scrofani, L.J. Fabri, P. Xu, P. Maccarone, and A.D. Nash Purification and refolding of vascular endothelial growth factor-B Protein Sci. 9 2000 2018 2025
47. T.K. Yeo, D.R. Senger, H.F. Dvorak, L. Freter, and K.T. Yeo Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor) Biochem. Biophys. Res. Commun. 179 1991 1568 1575
48. R. Di Stasi, D. Diana, D. Capasso, R. Palumbo, A. Romanelli, C. Pedone, R. Fattorusso, and L.D. D'Andrea VEGFR1(D2) in drug discovery: expression and molecular characterization Biopolymers 94 2010 800 809
49. A. Helenius How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum Mol. Biol. Cell 5 1994 253 265 (Pubitemid 24116952)
50. N.M. McKern, M. Lou, M.J. Frenkel, A. Verkuylen, J.D. Bentley, G.O. Lovrecz, N. Ivancic, T.C. Elleman, T.P. Garrett, L.J. Cosgrove, and C.W. Ward Crystallization of the first three domains of the human insulin-like growth factor-1 receptor Protein Sci. 6 1997 2663 2666 (Pubitemid 28006708)
51. V. Joukov, T. Sorsa, V. Kumar, M. Jeltsch, L. Claesson-Welsh, Y. Cao, O. Saksela, N. Kalkkinen, and K. Alitalo Proteolytic processing regulates receptor specificity and activity of VEGF-C EMBO J. 16 1997 3898 3911 (Pubitemid 27281006)
52. V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk, O. Saksela, N. Kalkkinen, and K. Alitalo A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases EMBO J. 15 1996 1751 (Pubitemid 26112397)